Degradation of N-hydroxy-3,4-methylenedioxymethamphetamine in aqueous solution and its prevention

Forensic Science International

Volumn 193, Issue 1-3, 2009, Pages 106-111

  Tsujikawa, Kenji ^a   Kuwayama, Kenji ^a   Miyaguchi, Hajime ^a   Kanamori, Tatsuyuki ^a   Iwata, Yuko T ^a   Inoue, Hiroyuki ^a  

^a NATIONAL RESEARCH INSTITUTE OF POLICE SCIENCE   (Japan)

Author keywords

Degradation; l Ascorbic acid; N Hydroxy 3,4 methylenedioxyamphetamine; N Hydroxy 3,4 methylenedioxymethamphetamine

Indexed keywords

ACETIC ACID ETHYL ESTER; ASCORBIC ACID; BUFFER; CHLOROFORM; N HYDROXY 3,4 METHYLENEDIOXYMETHAMPHETAMINE; OXIME DERIVATIVE; OXYGEN; PSYCHEDELIC AGENT; REACTIVE OXYGEN METABOLITE; SCAVENGER; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL STRUCTURE; CONJUGATE; DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; PH; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 70449639678     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.09.020     Document Type: Article

References (13)

1. Shulgin A.T., and Shulgin A. PiHKAL: A Chemical Love Story (1992), Transform Press, Berkeley
2. Keizers P.H.J., Lussenburg B.M.A., Graaf C., Mentink L.M., Vermeulen N.P.E., and Commandeur J.N.M. Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism. Biochem. Pharmacol. 68 (2004) 2263-2271
3. Noggle F.T., Clark C.R., DeRuiter J., and Cain P. Analytical properties of N-hydroxy-3,4-methylenedioxymethamphetamine ("FLEA"), a potential new street drug. Microgram 29 (1996) 10-21
4. Valaer A.K., Ravis W.R., and Clark C.R. Liquid chromatographic properties and aqueous solution stability of N-hydroxy-3,4-methylenedioxyamphetamine. J. Chromatogr. Sci. 28 (1990) 482-486
5. Lin J., and Cashman J.R. N-oxygenation of phenethylamine to trans-oxime by adult human liver flavin-containing monooxygenase and retroreduction of phenethylamine hydroxylamine by human liver microsomes. J. Pharmacol. Exp. Ther. 282 (1997) 1269-1279
6. Coutts R.T., Jones G.R., and Liu S.F. Identification of a nitrone as an in vitro metabolite of N-methylamphetamine. Biomed. Mass Spectrom. 5 (1978) 418-422
7. Beckett A.H., and Al-Sarraj S. The identification, properties and analysis of N-hydroxyamphetamine-a metabolite of amphetamine. J. Pharm. Pharmacol. 25 (1973) 329-334
8. Beckett A.H., and Al-Sarraj S. The mechanism of oxidation of amphetamine enantiomorphs by liver microsomal preparations from different species. J. Pharm. Pharmacol. 24 (1972) 174-176
9. Chatterjee I.B., and Nandi A. Ascorbic acid: a scavenger of oxyradicals. Indian J. Biochem. Biophys. 28 (1991) 233-236
10. In: Budavari S. (Ed). The Merck Index. 12th ed. (1996), Merck, Whitehouse Station
11. Garrett E.R., Seyda K., and Marroum P. High performance liquid chromatographic assays of the illicit designer drug "Ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding. Acta Pharm. Nord. 3 (1991) 9-14
12. Beckett A.H., Jones G.R., and Hollingsbee D.A. Degradation of (-)-ephedrine in solution and during extraction with diethylether. J. Pharm. Pharmacol. 30 (1978) 15-19
13. Beckett A.H., Navas G.E., and Hutt A.J. Metabolism of chlorpromazine and promazine in vitro: isolation and characterization of N-oxidation products. Xenobiotica 18 (1988) 61-74